EUVIMEDEUVIMED entdecken
Crossref

Necessity of HuR / ELAVL1 for the activation-induced cytidine deaminase-dependent decrease in topoisomerase 1 in antibody diversification

Wajid Amin, Shoki Nishio, Tasuku Honjo, Maki Kobayashi

International Immunology · 2023

DOI: 10.1093/intimm/dxad011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunology, 2023. Verfasst von Wajid Amin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Genomic Medicine, Center for Cancer Immunotherapy and Immunobiology, Graduate School of Medicine, Kyoto University, 606-…. Hauptthemen laut MEDLINE: Cytidine Deaminase, ELAV-Like Protein 1, DNA Topoisomerases, Type I, Antibodies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Japan Society for Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Activation-induced cytidine deaminase (AID)-dependent DNA cleavage is the initial event of antibody gene-diversification processes such as class switch recombination (CSR) and somatic hypermutation (SHM). We previously reported the requirement of an AID-dependent decrease of topoisomerase 1 (Top1) for efficient DNA cleavage, but the underlying molecular mechanism has remained elusive. This study focuses on HuR/ELAVL1, a protein that binds to AU-rich elements in RNA. HuR-knockout (KO) CH12 cells derived from murine B lymphoma cells were found to have lower CSR and hypermutation efficiencies due to decreased AID-dependent DNA cleavage levels. The HuR-KO CH12 cells do not show impairment in cell cycles and Myc expression, which have been reported in HuR-reduced spleen B cells. Furthermore, drugs that scavenge reactive oxygen species (ROS) do not rescue the lower CSR in HuR-KO CH12 cells, meaning that ROS or decreased c-Myc protein amount is not the reason for the deficiencies of CSR and hypermutation in HuR-KO CH12 cells. We show that HuR binds to Top1 mRNA and that complete deletion of HuR abolishes AID-dependent repression of Top1 protein synthesis in CH12 cells. Additionally, reduction of CSR to IgG3 in HuR-KO cells is rescued by knockdown of Top1, indicating that elimination of the AID-dependent Top1 decrease is the cause of the inefficiency of DNA cleavage, CSR and hypermutation in HuR-KO cells. These results show that HuR is required for initiation of antibody diversification and acquired immunity through the regulation of AID-dependent DNA cleavage by repressing Top1 protein synthesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytidine DeaminaseELAV-Like Protein 1DNA Topoisomerases, Type IAntibodiesImmunoglobulin Class SwitchingSomatic Hypermutation, ImmunoglobulinAnimalsMiceCell Line, TumorB-LymphocytesMice, Inbred C57BLGene Knockdown TechniquesAICDA (Activation-Induced Cytidine Deaminase)

Stichwörter der Autor:innen

AU-rich elementDNA cleavageclass switch recombination

Substanzen

AICDA (Activation-Induced Cytidine Deaminase)Cytidine DeaminaseElavl1 protein, mouseELAV-Like Protein 1DNA Topoisomerases, Type IAntibodies

Autor:innen und Institutionen

  • Department of Immunology and Genomic Medicine, Center for Cancer Immunotherapy and Immunobiology, Graduate School of Medicine, Kyoto University, 606-8501, Kyoto, Japan.

Förderung

  • Japan Society for Promotion of Science

Zitieren

APA

Amin, W., Nishio, S., Honjo, T., & Kobayashi, M. (2023). Necessity of HuR / ELAVL1 for the activation-induced cytidine deaminase-dependent decrease in topoisomerase 1 in antibody diversification. International Immunology. https://doi.org/10.1093/intimm/dxad011

Vancouver

Amin W, Nishio S, Honjo T, Kobayashi M. Necessity of HuR / ELAVL1 for the activation-induced cytidine deaminase-dependent decrease in topoisomerase 1 in antibody diversification. International Immunology. 2023. doi:10.1093/intimm/dxad011

BibTeX
@article{Amin2023,
  author = {Amin, Wajid and Nishio, Shoki and Honjo, Tasuku and Kobayashi, Maki},
  title = {Necessity of HuR / ELAVL1 for the activation-induced cytidine deaminase-dependent decrease in topoisomerase 1 in antibody diversification},
  journal = {International Immunology},
  year = {2023},
  doi = {10.1093/intimm/dxad011}
}
Kostenlos starten →